Talphera (TLPH) Return on Assets (2011 - 2025)

Talphera (TLPH) posted quarterly Return on Assets of 0.0% for Q4 2025, down 21.84% quarter-over-quarter from 0.0% in Q3 2025.

Talphera (TLPH) Return on Assets (2011 - 2025) Analysis & Trends

Talphera's Return on Assets history runs 15 years deep, the most recent figure standing at 0.0% for Q4 2025.

In Q4 2025, Return on Assets changed N/A year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
Return on Assets for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
The five-year high for Return on Assets was 0.0% in Q4 2023, with the low at 0.0% in Q3 2021.
The 5-year median for Return on Assets is 0.0% (2024), against an average of 0.0%.
The sharpest annual moves came in 2021 and 2023: Return on Assets changed 0 bps in 2021, then rose 1 bps in 2023.
Talphera's Return on Assets stood at 0.0% in 2021, then soared by 37 bps to 0.0% in 2022, then jumped by 261 bps to 0.0% in 2023, then slumped by 100 bps to 0.0% in 2024, then surged by 562 bps to 0.0% in 2025.
Business Quant data shows TLPH's Return on Assets at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	0.00%
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	0.00%
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	0.00%
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	0.00%
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	0.00%
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.00%
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	0.00%
10	Talphera	89.95 Mn	89.95 Mn	-	0.00%

Download Data